LU76706A1 - - Google Patents

Info

Publication number
LU76706A1
LU76706A1 LU76706A LU76706A LU76706A1 LU 76706 A1 LU76706 A1 LU 76706A1 LU 76706 A LU76706 A LU 76706A LU 76706 A LU76706 A LU 76706A LU 76706 A1 LU76706 A1 LU 76706A1
Authority
LU
Luxembourg
Application number
LU76706A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU76706A1 publication Critical patent/LU76706A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
LU76706A 1976-02-07 1977-02-04 LU76706A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762604845 DE2604845A1 (de) 1976-02-07 1976-02-07 Neue piperazinderivate

Publications (1)

Publication Number Publication Date
LU76706A1 true LU76706A1 (fr) 1977-06-28

Family

ID=5969327

Family Applications (1)

Application Number Title Priority Date Filing Date
LU76706A LU76706A1 (fr) 1976-02-07 1977-02-04

Country Status (25)

Country Link
US (1) US4079137A (fr)
JP (1) JPS52105186A (fr)
AT (1) AT355578B (fr)
AU (1) AU504526B2 (fr)
BE (1) BE850492A (fr)
CA (1) CA1094560A (fr)
CH (1) CH631448A5 (fr)
CS (1) CS201544B2 (fr)
DD (1) DD128133A5 (fr)
DE (1) DE2604845A1 (fr)
DK (1) DK138891C (fr)
ES (1) ES455691A1 (fr)
FI (1) FI63226C (fr)
FR (1) FR2340311A1 (fr)
GB (1) GB1550545A (fr)
HU (1) HU173483B (fr)
IE (1) IE44339B1 (fr)
IL (1) IL51316A (fr)
LU (1) LU76706A1 (fr)
NL (1) NL7700841A (fr)
NO (1) NO142625C (fr)
PL (1) PL105526B1 (fr)
PT (1) PT66154B (fr)
SE (1) SE7701187L (fr)
ZA (1) ZA77248B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4341698A (en) * 1979-06-21 1982-07-27 Richardson-Merrell Inc. Enkaphalin derivatives
US4483988A (en) * 1980-03-14 1984-11-20 Richardson Merrell Inc. Substituted derivatives of 4-t-alkoxycarbonyl-piperazin-2-ones
US4766125A (en) * 1981-06-23 1988-08-23 Janssen Pharmaceutica N.V. N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia
WO2006062917A2 (fr) * 2004-12-06 2006-06-15 Sciclone Pharmaceuticals, Inc. Peptides d'alpha thymosine en tant qu'adjuvants de vaccin anti-cancereux
US20080300166A1 (en) * 2007-06-01 2008-12-04 Sciclone Pharmaceuticals, Inc. Treatment of Melanoma with Alpha Thymosin Peptides
WO2009075813A1 (fr) * 2007-12-12 2009-06-18 Sciclone Pharmaceuticals, Inc. Traitement d'un mélanome avec des peptides d'alpha-thymosine en association avec des anticorps contre l'antigène 4 associé au lymphocyte t cytotoxique (ctla4)
WO2009076587A1 (fr) * 2007-12-13 2009-06-18 Sciclone Pharmaceuticals, Inc. Traitement de mélanome par des peptides d'alpha thymosine en association avec un inhibiteur de kinase
JP2011506467A (ja) * 2007-12-14 2011-03-03 サイクローン・ファーマシューティカルズ・インコーポレイテッド 抗悪性腫瘍性熱ショックアポトーシス活性化因子（ｈｓａａ）と組み合わせられたアルファチモシンペプチドによる黒色腫の処置の方法
US8829173B2 (en) 2008-09-26 2014-09-09 Tocagen Inc. Recombinant vectors
JP2012526149A (ja) * 2009-05-08 2012-10-25 サイクローン・ファーマシューティカルズ・インコーポレイテッド ワクチン増強剤としてのαチモシンペプチド
CN107148279B (zh) 2014-10-21 2021-09-03 赛生药品股份国际有限公司 用免疫刺激剂治疗癌症

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3472856A (en) * 1967-05-29 1969-10-14 Sterling Drug Inc 1-((thianaphthenyl)-lower-alkyl)-4-substituted-piperazines
DE2438725A1 (de) * 1974-08-12 1976-02-26 Knoll Ag Piperazinderivate
US4031216A (en) * 1974-08-12 1977-06-21 Knoll A.G. Chemische Fabriken 3-(3,4-Dialkoxy-benzyl)-3-methyl-piperazines

Also Published As

Publication number Publication date
FI63226B (fi) 1983-01-31
CS201544B2 (en) 1980-11-28
FR2340311B1 (fr) 1980-02-08
IL51316A0 (en) 1977-03-31
NO142625C (no) 1980-09-17
IE44339L (en) 1977-08-07
FI770398A7 (fr) 1977-08-08
DK49077A (da) 1977-08-08
US4079137A (en) 1978-03-14
DD128133A5 (de) 1977-11-02
SE7701187L (sv) 1977-08-08
PL105526B1 (pl) 1979-10-31
NO142625B (no) 1980-06-09
CH631448A5 (de) 1982-08-13
NL7700841A (nl) 1977-08-09
ATA68177A (de) 1979-08-15
PT66154B (fr) 1978-07-07
JPS52105186A (en) 1977-09-03
DK138891B (da) 1978-11-13
ZA77248B (en) 1977-11-30
PT66154A (fr) 1977-03-01
IE44339B1 (en) 1981-10-21
IL51316A (en) 1980-12-31
AT355578B (de) 1980-03-10
DK138891C (da) 1979-04-23
CA1094560A (fr) 1981-01-27
FI63226C (fi) 1983-05-10
DE2604845A1 (de) 1977-08-18
HU173483B (hu) 1979-05-28
GB1550545A (en) 1979-08-15
AU504526B2 (en) 1979-10-18
BE850492A (fr) 1977-07-18
ES455691A1 (es) 1978-01-01
AU2195277A (en) 1978-08-10
NO770374L (no) 1977-08-09
FR2340311A1 (fr) 1977-09-02

Similar Documents

Publication Publication Date Title
FR2346663B3 (fr)
FR2353333B1 (fr)
FR2344899B1 (fr)
FR2340311B1 (fr)
JPS52106754U (fr)
JPS52148744U (fr)
JPS52104067U (fr)
JPS5368695U (fr)
JPS554993Y2 (fr)
JPS5552903Y2 (fr)
JPS5366620U (fr)
JPS52116999U (fr)
JPS5321754U (fr)
CS177446B1 (fr)
CS175337B1 (fr)
JPS52158924U (fr)
CS175524B1 (fr)
JPS52102873U (fr)
JPS52165095U (fr)
CH599772A5 (fr)
DD124424A1 (fr)
DD125837A1 (fr)
DD125692A1 (fr)
DD124637A1 (fr)
DD123966A1 (fr)